{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:20:39Z","timestamp":1740144039190,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"verrica pharmaceuticals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s40257-021-00635-2","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T15:10:50Z","timestamp":1631545850000},"page":"867-875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts"],"prefix":"10.1007","volume":"22","clinical-trial-number":[{"clinical-trial-number":"nct03981822","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-2245","authenticated-orcid":false,"given":"Scott","family":"Guenthner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"McFalda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melita","family":"Tate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Eads","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayson","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Glover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Willson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-958X","authenticated-orcid":false,"given":"Pamela","family":"Rumney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5946-5529","authenticated-orcid":false,"given":"Ted","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5537-980X","authenticated-orcid":false,"given":"Jennifer","family":"Andres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3692-5278","authenticated-orcid":false,"given":"Melissa","family":"Olivadoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"3","key":"635_CR1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.12891\/ceog4112.2018","volume":"45","author":"MA Recanati","year":"2018","unstructured":"Recanati MA, Kramer KJ, Maggio JJ, Chao CR. Cantharidin is superior to trichloroacetic acid for the treatment of non-mucosal genital warts: a pilot randomized controlled trial. Clin Exp Obstet Gynecol. 2018;45(3):383\u20136.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"13","key":"635_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2334-13-39","volume":"25","author":"H Patel","year":"2013","unstructured":"Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;25(13):39.","journal-title":"BMC Infect Dis"},{"key":"635_CR3","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted infections (STIs) are very common and costly to the nation's health and economy. Sexually transmitted diseases (STDs) 2020. 25 January 2021. https:\/\/www.cdc.gov\/std\/statistics\/prevalence-2020-at-a-glance.htm. Accessed 24 Apr 2021."},{"key":"635_CR4","unstructured":"Centers for Disease Control and Prevention. Genital HPV infection: fact sheet. 19 January 2021. https:\/\/www.cdc.gov\/std\/hpv\/stdfact-hpv.htm. Accessed 1 Jul 2021."},{"issue":"3","key":"635_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00128071-200001030-00001","volume":"1","author":"JA Leman","year":"2000","unstructured":"Leman JA, Benton EC. Verrucas. Am J Clin Dermatol. 2000;1(3):143\u20139.","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"635_CR6","first-page":"25","volume":"5","author":"VR Yanofsky","year":"2012","unstructured":"Yanofsky VR, Patel RV, Goldenberg G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol. 2012;5(6):25\u201336.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"4","key":"635_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1086\/514964","volume":"27","author":"KR Beutner","year":"1998","unstructured":"Beutner KR, Reitano MV, Richwald GA, Wiley DJ, Warts AEPoEG. external genital warts: report of the American Medical Association consensus conference. Clin Infect Dis. 1998;27(4):796\u2013806.","journal-title":"Clin Infect Dis"},{"key":"635_CR8","doi-asserted-by":"crossref","unstructured":"Dediol I, Buljan M, Vurnek-? Ivkovi? M, Bulat V, itum M. Psychological burden of anogenital warts. J Eur Acad Dermatol Venereol. 2009;23(9):1035\u20138.","DOI":"10.1111\/j.1468-3083.2009.03242.x"},{"issue":"6","key":"635_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0190-9622(98)70268-3","volume":"39","author":"AL Allen","year":"1998","unstructured":"Allen AL, Siegfried EC. The natural history of condyloma in children. J Am Acad Dermatol. 1998;39(6):951\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"635_CR10","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/jdv.16522","volume":"34","author":"R Gilson","year":"2020","unstructured":"Gilson R, Nugent D, Werner R, Ballesteros J, Ross J. 2019 IUSTI-Europe guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol. 2020;34(8):1644\u201353.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"635_CR11","first-page":"18559","volume":"19","author":"N Scheinfeld","year":"2013","unstructured":"Scheinfeld N. Update on the treatment of genital warts. Dermatol Online J. 2013;19(6):18559.","journal-title":"Dermatol Online J"},{"issue":"1","key":"635_CR12","first-page":"11","volume":"93","author":"JH Epstein","year":"1960","unstructured":"Epstein JH, Epstein WL. Cantharidin treatment of digital and periungual warts. Calif Med. 1960;93(1):11.","journal-title":"Calif Med"},{"issue":"2","key":"635_CR13","first-page":"27","volume":"12","author":"JQ Del Rosso","year":"2019","unstructured":"Del Rosso JQ, Kircik L. Topical cantharidin in the management of molluscum contagiosum: preliminary assessment of an ether-free, pharmaceutical-grade formulation. J Clin Aesthet Dermatol. 2019;12(2):27\u201330.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"12","key":"635_CR14","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamadermatol.2020.3238","volume":"156","author":"LF Eichenfield","year":"2020","unstructured":"Eichenfield LF, McFalda W, Brabec B, Siegfried E, Kwong P, McBride M, et al. Safety and efficacy of VP-102, a proprietary, drug-device combination product containing cantharidin, 0.7%(w\/v), in children and adults with molluscum contagiosum: two phase 3 randomized clinical trials. JAMA Dermatol. 2020;156(12):1315\u201323.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"635_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40257-020-00570-8","volume":"22","author":"LF Eichenfield","year":"2021","unstructured":"Eichenfield LF, Siegfried E, Kwong P, McBride M, Rieger J, Glover D, et al. Pooled results of two randomized phase III trials evaluating VP-102, a drug-device combination product containing cantharidin 0.7%(w\/v) for the treatment of nolluscum contagiosum. Am J Clin Dermatol. 2021;22(2):257\u201365.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"635_CR16","doi-asserted-by":"publisher","first-page":"e20151968","DOI":"10.1542\/peds.2015-1968","volume":"137","author":"LE Markowitz","year":"2016","unstructured":"Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics. 2016;137(3):e20151968.","journal-title":"Pediatrics"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00635-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-021-00635-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00635-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T02:43:22Z","timestamp":1673232202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-021-00635-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1007\/s40257-021-00635-2","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"type":"print","value":"1175-0561"},{"type":"electronic","value":"1179-1888"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"26 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Verrica Pharmaceuticals Inc. provided funding for the trial, as well as support for manuscript writing and figure creation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Drs. Guenthner, McFalda, and Tate received funding for clinical trials. Drs. Rieger and Glover are employees of PBM Capital Group. Dr. Andres, Ms. Willson, and Ms. Rumney are employees of Verrica Pharmaceuticals Inc. Dr. Olivadoti was an employee of Verrica Pharmaceuticals Inc. Dr. Rosen is a consultant for Verrica in activities unrelated to this trial.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"The study was conducted in accordance with Good Clinical Practice (GCP) as required by the International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use (ICH) guidelines and in accordance with country-specific laws and regulations governing clinical studies of investigational products.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"An Information and Consent form approved by a study site\u2019s institutional review board (IRB) was signed by the participants or legal representative and the Investigator before enrollment of participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are not publicly available as they are proprietary and under review with the FDA.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Concept and design: Willson, Rumney, Glover, Rieger. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: All authors. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Willson, Rumney. Obtained funding: Willson, Rumney. Administrative, technical, or material support: All Authors. Supervision: All Authors","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}